On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
about
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesisMethylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function.Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma.Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancerLung cancer cell lines as tools for biomedical discovery and researchMonocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis.Characterization of a murine model of metastatic human non-small cell lung cancer and effect of CXCR4 inhibition on the growth of metastasesAnimal models and molecular imaging tools to investigate lymph node metastasesMouse models of advanced spontaneous metastasis for experimental therapeutics.STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases.High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors.Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs.Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer.Human tumor xenografts and mouse models of human tumors: re-discovering the models.Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers.First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study.Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
P2860
Q29614537-0CF9BCBD-8787-4E17-925C-E9DD5F15D21DQ33627677-DD8A3531-9FE6-4A2E-BAF1-D66271D1404DQ33728605-23BC7680-28F4-4560-9955-0992545F1BF8Q33767013-DD29A804-DE9B-44ED-81E9-C8C1579B9D53Q34110617-0426173F-0258-4061-A368-4828EF4F030AQ34626551-4E1CB7C0-B5A3-44DB-AC57-8F280AAC552BQ34963659-D87299EA-324E-4719-B65B-935899E150E9Q35376170-0F8510F6-620A-45D5-87EB-E7140614FE6DQ35720139-D903F602-DA1E-4421-92E7-6AC72FF6E3C8Q35966786-270B3243-3BE9-480C-9730-6D73165BE0D3Q36343768-95D0E3E1-6C0F-4A2B-947C-3B064762ABBDQ36608597-B5C1269A-9C86-4E51-AECF-3D9C2BD29BACQ37336482-9C5ADA2E-80DA-48EA-9156-10B24C0422B1Q37345234-7706B603-31F7-4FAE-A2BB-3D8F5FE9C1ACQ37411781-57830907-5BDB-428A-B37E-55C5D7F684CAQ38088348-DA2C1B25-5DF0-4661-91BD-41264696383CQ42067472-907B56AE-673A-441C-8321-53CB25D57FE4Q48686558-122E120C-8E86-48C9-A1F0-2659D566D289Q55144204-FCF99BB6-A546-4153-A04C-2B15CD74781A
P2860
On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
On the development of models i ...... for anti-cancer drug testing.
@en
type
label
On the development of models i ...... for anti-cancer drug testing.
@en
prefLabel
On the development of models i ...... for anti-cancer drug testing.
@en
P1476
On the development of models i ...... e for anti-cancer drug testing
@en
P2093
Robert S Kerbel
P2888
P304
P356
10.1007/S10555-007-9087-6
P50
P577
2007-12-01T00:00:00Z